Butalbital en es it fr

Butalbital Brand names, Butalbital Analogs

Butalbital Brand Names Mixture

  • Fiorinal C1/2 Cap (Acetylsalicylic Acid + Butalbital + Caffeine + Codeine Phosphate)
  • Fiorinal C1/4 Cap (Acetylsalicylic Acid + Butalbital + Caffeine + Codeine Phosphate)
  • Fiorinal Tab (Acetylsalicylic Acid + Butalbital + Caffeine)
  • Ratio-Tecnal (Acetylsalicylic Acid + Butalbital + Caffeine)
  • Ratio-Tecnal C 1/2 (Acetylsalicylic Acid + Butalbital + Caffeine + Codeine Phosphate)
  • Ratio-Tecnal C1/4 (Acetylsalicylic Acid + Butalbital + Caffeine + Codeine Phosphate)
  • Trianal Capsules (Acetylsalicylic Acid + Butalbital + Caffeine)
  • Trianal Tablet (Acetylsalicylic Acid + Butalbital + Caffeine)
  • Trianal-C 1/2 Capsule (Acetylsalicylic Acid + Butalbital + Caffeine + Codeine Phosphate)

Butalbital Chemical_Formula

C11H16N2O3

Butalbital RX_link

http://www.rxlist.com/cgi/generic/esgic.htm

Butalbital fda sheet

Butalbital msds (material safety sheet)

Butalbital Synthesis Reference

J. Am. Chem. Soc. 47, 2236 (1925)

Butalbital Molecular Weight

224.256 g/mol

Butalbital Melting Point

138-139 oC

Butalbital H2O Solubility

1700 mg/L

Butalbital State

Solid

Butalbital LogP

1.429

Butalbital Dosage Forms

Tablet

Butalbital Indication

Used in combination with acetaminophen or aspirin and caffeine for its sedative and relaxant effects in the treatment of tension headaches, migraines, and pain.

Butalbital Pharmacology

Butalbital is a short to intermediate-acting barbiturate. Barbiturates act as nonselective depressants of the central nervous system (CNS), capable of producing all levels of CNS mood alteration from excitation to mild sedation, hypnosis, and deep coma. In sufficiently high therapeutic doses, barbiturates induce anesthesia.

Butalbital Absorption

Well absorbed from the gastrointestinal tract and is expected to distribute to most tissues in the body.

Butalbital side effects and Toxicity

Symptoms of acute barbiturate poisoning include drowsiness, confusion, coma, respiratory depression, hypotension, and shock.

Butalbital Patient Information

PATIENT INFORMATION
This product may impair mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. Such tasks should be avoided while taking this product.
Alcohol and other CNS depressants may produce an additive CNS depression, when taken with this combination product, and should be avoided.
Butalbital may be habit-forming. Patients should take the drug only for as long as it is prescribed, in the amounts prescribed, and no more frequently than prescribed.

Butalbital Organisms Affected

Humans and other mammals